(Q3)Jan 31, 2023 | (Q2)Oct 31, 2022 | (Q1)Jul 31, 2022 | (FY)Apr 30, 2022 | (Q4)Apr 30, 2022 | (Q3)Jan 31, 2022 | (Q2)Oct 31, 2021 | (Q1)Jul 31, 2021 | (FY)Apr 30, 2021 | (Q4)Apr 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -6.07%-366.93K | -2.52%-274.36K | 6.64%-280.78K | -0.33%-1.19M | 2.83%-275.96K | 3.47%-345.92K | 9.33%-267.61K | -20.86%-300.74K | 35.90%-1.19M | 26.28%-283.99K |
Net income from continuing operations | -60.03%-479.65K | -7.10%-337K | -15.99%-476.2K | 72.34%-1.35M | 73.39%-329.96K | 76.43%-299.73K | 73.86%-314.67K | 65.33%-410.57K | 4.25%-4.9M | -8.76%-1.24M |
Depreciation and amortization | -29.81%445 | -12.78%553 | -29.86%444 | -65.26%2.53K | -7.46%633 | -14.32%634 | -21.53%634 | -87.50%633 | 61.19%7.29K | 119.23%684 |
Change In working capital | 339.76%112.28K | 33.76%62.09K | 78.55%194.98K | -95.62%162.16K | -94.41%53.37K | -105.13%-46.83K | -94.89%46.42K | -88.26%109.2K | 16.10%3.71M | 25.04%955.1K |
-Change in receivables | 191.61%3.28K | 340.98%9.98K | -41.57%-4.17K | -509.06%-13.77K | -205.73%-3.1K | -5.83%-3.58K | -368.50%-4.14K | -229.94%-2.95K | 196.81%3.37K | 183.25%2.93K |
-Change in prepaid assets | 84.91%-2.44K | 8.14%14.25K | -72.93%6.23K | 178.82%37.16K | 49.19%17.12K | 71.50%-16.15K | -22.53%13.17K | 221.37%23.02K | -233.39%-47.15K | 514.95%11.48K |
-Change in payables and accrued expense | 511.10%111.44K | 1.26%37.86K | 116.45%192.92K | -96.30%138.76K | -95.82%39.35K | -102.79%-27.11K | -95.80%37.39K | -90.59%89.13K | 18.66%3.75M | 22.94%941.12K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -6.07%-366.93K | -2.52%-274.36K | 6.64%-280.78K | -0.33%-1.19M | 2.83%-275.96K | 3.47%-345.92K | 9.33%-267.61K | -20.86%-300.74K | 35.90%-1.19M | 26.28%-283.99K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -7.67K | 0 | 0 | 0 | 96.18%-879 | 0 | ||||
Net PPE purchase and sale | ---7.67K | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 96.10%-879 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---7.67K | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 96.18%-879 | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -4.00%360K | -33.33%150K | 70.00%425K | 15.79%1.1M | 25.00%250K | -25.00%375K | 73.08%225K | 108.33%250K | -52.02%950K | -66.67%200K |
Net issuance payments of debt | -4.00%360K | -33.33%150K | 70.00%425K | 15.79%1.1M | 25.00%250K | -25.00%375K | 73.08%225K | 108.33%250K | -52.02%950K | -66.67%200K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -4.00%360K | -33.33%150K | 70.00%425K | 15.79%1.1M | 25.00%250K | -25.00%375K | 73.08%225K | 108.33%250K | -52.02%950K | -66.67%200K |
Net cash flow | ||||||||||
Beginning cash position | 103.02%35.19K | 174.71%164.68K | -81.52%20.46K | -68.18%110.68K | -76.16%46.41K | -67.32%17.34K | -72.63%59.95K | -68.18%110.68K | 43.92%347.89K | 36.02%194.67K |
Current changes in cash | -150.18%-14.59K | -203.87%-129.48K | 384.24%144.22K | 61.96%-90.23K | 69.09%-25.96K | -79.47%29.08K | 74.33%-42.61K | 60.62%-50.74K | -323.43%-237.2K | -141.02%-83.99K |
End cash Position | -55.61%20.6K | 103.02%35.19K | 174.71%164.68K | -81.52%20.46K | -81.52%20.46K | -76.16%46.41K | -67.32%17.34K | -72.63%59.95K | -68.18%110.68K | -68.18%110.68K |
Free cash from | -8.29%-374.59K | -4.44%-279.48K | 6.64%-280.78K | -0.25%-1.19M | 2.83%-275.96K | 3.47%-345.92K | 9.60%-267.61K | -20.86%-300.74K | 36.63%-1.19M | 28.15%-283.99K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data